Planned | Unplanned | |||||||
---|---|---|---|---|---|---|---|---|
n (%) | Median | Q1-Q3 | Min-max | n (%) | Median | Q1-Q3 | Min-max | |
Arthrosis (M15-M19) | ||||||||
Total | 42 (8.9) | 2 | 1–2 | 1–5 | 12 (2.5) | 1 | 1–1 | 1–2 |
Women | 30 (13.3) | 2 | 1–2 | 1–5 | 9 (4.0) | 1 | 1–1 | 1–2 |
Men | 12 (4.9) | 1 | 1–4 | 1–5 | 3 (1.2) | 1 | 1–1 | 1–1 |
Cataract (H25-H26) | ||||||||
Total | 155 (32.) | 1 | 1–2 | 1–3 | 8 (1.7) | 1 | 1–1 | 1–1 |
Women | 90 (40.0) | 1 | 1–2 | 1–3 | 5 (2.2) | 1 | 1–1 | 1–1 |
Men | 65 (26.3) | 1 | 1–2 | 1–3 | 3 (1.2) | 1 | 1–1 | 1–1 |
Constipation (K59) | ||||||||
Total | 11 (2.3) | 1 | 1–1 | 1–3 | 22 (4.7) | 1 | 1–2 | 1–7 |
Women | 6 (2.7) | 1 | 1–1 | 1–1 | 11 (4.9) | 1 | 1–2 | 1–7 |
Men | 5 (2.0) | 1 | 1–2 | 1–3 | 11 (4.5) | 1 | 1–1 | 1–3 |
Dementia (F00, F03.9, G30) | ||||||||
Total | 31 (6.6) | 1 | 1–2 | 1–4 | ||||
Women | 20 (8.9) | 1 | 1–2 | 1–3 | ||||
Men | 11 (4.5) | 1 | 1–2 | 1–4 | ||||
Diabetes mellitus (E10-E14) | ||||||||
Total | 15 (3.2) | 1 | 1–3 | 1–11 | ||||
Women | 8 (3.6) | 1 | 1–2 | 1–11 | ||||
Men | 7 (2.8) | 2 | 1–3 | 1–3 | ||||
Epilepsy or seizure (G40-G41, R56.8) | ||||||||
Total | 42 (8.9) | 1 | 1–2 | 1–6 | 93 (19.7) | 1 | 1–2 | 1–30 |
Women | 32 (14.2) | 1 | 1–2 | 1–6 | 62 (27.6) | 1 | 1–2 | 1–30 |
Men | 10 (4.1) | 1 | 1–2 | 1–3 | 31 (12.6) | 1 | 1–1 | 1–4 |
Hearing loss (H90-H91) | ||||||||
Total | 10 (2.1) | 1 | 1–1 | 1–2 | ||||
Women | 3 (1.3) | 1 | 1–1 | 1–1 | ||||
Men | 7 (2.8) | 1 | 1–1 | 1–2 | ||||
Impacted cerumen (H61.2) | ||||||||
Total | 19 (4.0) | 1 | 1–1 | 1–5 | ||||
Women | 9 (4.0) | 1 | 1–1 | 1–2 | ||||
Men | 10 (4.0) | 1 | 1–1 | 1–5 | ||||
Keratoconus (H18.6) | ||||||||
Total | 11 (2.3) | 1 | 1–2 | 1–2 | ||||
Women | 4 (1.8) | 1 | 1–2 | 1–2 | ||||
Men | 7 (2.8) | 1 | 1–2 | 1–2 | ||||
Pneumonia (J12-J15, J18, J69.0) | ||||||||
Total | 128 (27.1) | 1 | 1–1 | 1–5 | ||||
Women | 46 (20.4) | 1 | 1–1 | 1–5 | ||||
Men | 82 (33.2) | 1 | 1–2 | 1–4 |